[1]
|
Deng, L.D., Qi, L., Suo, Q., et al. (2022) Transcranial Focused Ultrasound Stimulation Reduces Vasogenic Edema after Middle Cerebral Artery Occlusion in Mice. Neural Regeneration Research, 17, 2058-2063. https://doi.org/10.4103/1673-5374.335158
|
[2]
|
Nawabi, J., Flottmann, F., Hanning, U., et al. (2019) Futile Recanalization with Poor Clinical Outcome Is Associated with Increased Edema Volume after Ischemic Stroke. Investigative Radiology, 54, 282-287. https://doi.org/10.1097/RLI.0000000000000539
|
[3]
|
Yao, Y., Zhang, Y., Liao, X., et al. (2020) Potential Therapies for Cerebral Edema after Ischemic Stroke: A Mini Review. Frontiers in Aging Neuroscience, 12, Article ID: 618819. https://doi.org/10.3389/fnagi.2020.618819
|
[4]
|
Liebeskind, D.S., Jüttler, E., Shapovalov, Y., et al. (2019) Cerebral Edema Associated with Large Hemispheric Infarction. Stroke, 50, 2619-2625. https://doi.org/10.1161/STROKEAHA.118.024766
|
[5]
|
Jha, R.M., Kochanek, P.M. and Simard, J.M. (2019) Pathophysiology and Treatment of Cerebral Edema in Traumatic Brain Injury. Neuropharmacology, 145, 230-246. https://doi.org/10.1016/j.neuropharm.2018.08.004
|
[6]
|
Jiang, X., Andjelkovic, A.V., Zhu, L., et al. (2018) Blood-Brain Barrier Dysfunction and Recovery after Ischemic Stroke. Progress in Neurobiology, 163-164, 144-171. https://doi.org/10.1016/j.pneurobio.2017.10.001
|
[7]
|
Ji, C., Yu, X., Xu, W., et al. (2021) The Role of Glymphatic System in the Cerebral Edema Formation after Ischemic Stroke. Experimental Neurology, 340, Article ID: 113685. https://doi.org/10.1016/j.expneurol.2021.113685
|
[8]
|
Halstead, M.R. and Geocadin, R.G. (2019) The Medical Management of Cerebral Edema: Past, Present, and Future Therapies. Neurotherapeutics, 16, 1133-1148. https://doi.org/10.1007/s13311-019-00779-4
|
[9]
|
Stokum, J.A., Gerzanich, V. and Simard, J.M. (2016) Molecular Pathophysiology of Cerebral Edema. Journal of Cerebral Blood Flow & Metabolism, 36, 513-538. https://doi.org/10.1177/0271678X15617172
|
[10]
|
MacAulay, N. (2021) Molecular Mechanisms of Brain Water Transport. Nature Reviews Neuroscience, 22, 326-344. https://doi.org/10.1038/s41583-021-00454-8
|
[11]
|
MacAulay, N. and Zeuthen, T. (2010) Water Transport between CNS Compartments: Contributions of Aquaporins and Cotransporters. Neuroscience, 168, 941-956. https://doi.org/10.1016/j.neuroscience.2009.09.016
|
[12]
|
Chen, S., Shao, L. and Ma, L. (2021) Cerebral Edema Formation after Stroke: Emphasis on Blood-Brain Barrier and the Lymphatic Drainage System of the Brain. Frontiers in Cellular Neuroscience, 15, Article ID: 716825. https://doi.org/10.3389/fncel.2021.716825
|
[13]
|
Zhang, C., Jiang, M., Wang, W.Q., et al. (2020) Selective MGluR1 Negative Allosteric Modulator Reduces Blood-Brain Barrier Permeability and Cerebral Edema after Experimental Subarachnoid Hemorrhage. Translational Stroke Research, 11, 799-811. https://doi.org/10.1007/s12975-019-00758-z
|
[14]
|
Garcia, J.G., Siflinger-Birnboim, A., Bizios, R., et al. (1986) Thrombin-Induced Increase in Albumin Permeability across the Endothelium. Journal of Cellular Physiology, 128, 96-104. https://doi.org/10.1002/jcp.1041280115
|
[15]
|
Moy, A.B., Van, Engelenhoven, J., Bodmer, J., et al. (1996) Histamine and Thrombin Modulate Endothelial Focal Adhesion through Centripetal and Centrifugal Forces. Journal of Clinical Investigation, 97, 1020-1027. https://doi.org/10.1172/JCI118493
|
[16]
|
Dore-Duffy, P., Wang, X., Mehedi, A., et al. (2007) Differential Expression of Capillary VEGF Isoforms Following Traumatic Brain Injury. Neurological Research, 29, 395-403. https://doi.org/10.1179/016164107X204729
|
[17]
|
Zhang, Z.G., Zhang, L., Jiang, Q., et al. (2000) VEGF Enhances Angiogenesis and Promotes Blood-Brain Barrier Leakage in the Ischemic Brain. Journal of Clinical Investigation, 106, 829-838. https://doi.org/10.1172/JCI9369
|
[18]
|
Starling, E.H. (1896) On the Absorption of Fluids from the Connective Tissue Spaces. The Journal of Physiology, 19, 312-326. https://doi.org/10.1113/jphysiol.1896.sp000596
|
[19]
|
Simard, J.M., Kent, T.A., Chen, M., et al. (2007) Brain Oedema in Focal Ischaemia: Molecular Pathophysiology and Theoretical Implications. The Lancet Neurology, 6, 258-268. https://doi.org/10.1016/S1474-4422(07)70055-8
|
[20]
|
Stokum, J.A., Kwon, M.S., Woo, S.K., et al. (2018) SUR1-TRPM4 and AQP4 Form a Heteromultimeric Complex That Amplifies Ion/Water Osmotic Coupling and Drives Astrocyte Swelling. Glia, 66, 108-125. https://doi.org/10.1002/glia.23231
|
[21]
|
Stokum, J.A., Kurland, D.B., Gerzanich, V., et al. (2015) Mechanisms of Astrocyte-Mediated Cerebral Edema. Neurochemical Research, 40, 317-328. https://doi.org/10.1007/s11064-014-1374-3
|
[22]
|
Liu, E., Sun, L., Zhang, Y., et al. (2020) Aquaporin4 Knockout Aggravates Early Brain Injury Following Subarachnoid Hemorrhage through Impairment of the Glymphatic System in Rat Brain. Acta Neurochirurgica Supplement, 127, 59-64. https://doi.org/10.1007/978-3-030-04615-6_10
|
[23]
|
Mestre, H., Du, T., Sweeney, A.M., et al. (2020) Cerebrospinal Fluid Influx Drives Acute Ischemic Tissue Swelling. Science, 367, eaax7171. https://doi.org/10.1126/science.aax7171
|
[24]
|
Sadana, P., Coughlin, L., Burke, J., et al. (2015) Anti-Edema Action of Thyroid Hormone in MCAO Model of Ischemic Brain Stroke: Possible Association with AQP4 Modulation. Journal of the Neurological Sciences, 354, 37-45. https://doi.org/10.1016/j.jns.2015.04.042
|
[25]
|
Wei, X., Zhang, B., Cheng, L., et al. (2015) Hydrogen Sulfide Induces Neuroprotection against Experimental Stroke in Rats by Down-Regulation of AQP4 via Activating PKC. Brain Research, 1622, 292-299. https://doi.org/10.1016/j.brainres.2015.07.001
|
[26]
|
Catalin, B., Rogoveanu, O.C., Pirici, I., et al. (2018) Cerebrolysin and Aquaporin 4 Inhibition Improve Pathological and Motor Recovery after Ischemic Stroke. CNS & Neurological Disorders-Drug Targets, 17, 299-308. https://doi.org/10.2174/1871527317666180425124340
|
[27]
|
Pirici, I., Balsanu, T.A., Bogdan, C., et al. (2017) Inhibition of Aquaporin-4 Improves the Outcome of Ischaemic Stroke and Modulates Brain Paravascular Drainage Pathways. International Journal of Molecular Sciences, 19, Article No. 46. https://doi.org/10.3390/ijms19010046
|
[28]
|
Clément, T., Rodriguez-Grande, B. and Badaut, J. (2020) Aquaporins in Brain Edema. Journal of Neuroscience Research, 98, 9-18. https://doi.org/10.1002/jnr.24354
|
[29]
|
Alquisiras-Burgos, I., Franco-Pérez, J., Rubio-Osornio, M., et al. (2022) The Short Form of the SUR1 and Its Functional Implications in the Damaged Brain. Neural Regeneration Research, 17, 488-496. https://doi.org/10.4103/1673-5374.320967
|
[30]
|
Alquisiras-Burgos, I., Ortiz-Plata, A., Franco-Pérez, J., et al. (2020) Resveratrol Reduces Cerebral Edema through Inhibition of De Novo SUR1 Expression Induced after Focal Ischemia. Experimental Neurology, 330, Article ID: 113353. https://doi.org/10.1016/j.expneurol.2020.113353
|
[31]
|
Mehta, R.I., Ivanova, S., Tosun, C., et al. (2013) Sulfonylurea Receptor 1 Expression in Human Cerebral Infarcts. Journal of Neuropathology & Experimental Neurology, 72, 871-883. https://doi.org/10.1097/NEN.0b013e3182a32e40
|
[32]
|
Jha, R.M., Rani, A., Desai, S.M., et al. (2021) Sulfonylurea Receptor 1 in Central Nervous System Injury: An Updated Review. International Journal of Molecular Sciences, 22, Article No. 11899. https://doi.org/10.3390/ijms222111899
|
[33]
|
Chen, B., Ng, G., Gao, Y., et al. (2019) Non-Invasive Multimodality Imaging Directly Shows TRPM4 Inhibition Ameliorates Stroke Reperfusion Injury. Translational Stroke Research, 10, 91-103. https://doi.org/10.1007/s12975-018-0621-3
|
[34]
|
Chen, B., Gao, Y., Wei, S., et al. (2019) TRPM4-Specific Blocking Antibody Attenuates Reperfusion Injury in a Rat Model of Stroke. Pflügers Archiv, 471, 1455-1466. https://doi.org/10.1007/s00424-019-02326-8
|
[35]
|
Wang, X., Chang, Y., He, Y., et al. (2020) Glimepiride and Glibenclamide Have Comparable Efficacy in Treating Acute Ischemic Stroke in Mice. Neuropharmacology, 162, Article ID: 107845. https://doi.org/10.1016/j.neuropharm.2019.107845
|
[36]
|
Pergakis, M., Badjatia, N., Chaturvedi, S., et al. (2019) BIIB093 (IV Glibenclamide): An Investigational Compound for the Prevention and Treatment of Severe Cerebral Edema. Expert Opinion on Investigational Drugs, 28, 1031-1040. https://doi.org/10.1080/13543784.2019.1681967
|
[37]
|
Vorasayan, P., Bevers, M.B., Beslow, L.A., et al. (2019) Intravenous Glibenclamide Reduces Lesional Water Uptake in Large Hemispheric Infarction. Stroke, 50, 3021-3027. https://doi.org/10.1161/STROKEAHA.119.026036
|
[38]
|
Huang, K., Hu, Y., Wu, Y., et al. (2019) Exploratory Analysis of Oral Glibenclamide in Acute Ischemic Stroke. Acta Neurologica Scandinavica, 140, 212-218. https://doi.org/10.1111/ane.13134
|
[39]
|
Kurzepa, J., Kurzepa, J., Golab, P., et al. (2014) The Significance of Matrix Metalloproteinase (MMP)-2 and MMP-9 in the Ischemic Stroke. International Journal of Neuroscience, 124, 707-716. https://doi.org/10.3109/00207454.2013.872102
|
[40]
|
Turner, R.J. and Sharp, F.R. (2016) Implications of MMP9 for Blood Brain Barrier Disruption and Hemorrhagic Transformation Following Ischemic Stroke. Frontiers in Cellular Neuroscience, 10, Article No. 56. https://doi.org/10.3389/fncel.2016.00056
|
[41]
|
Sifat A.E., Vaidya, B. and Abbruscato, T.J. (2017) Blood-Brain Barrier Protection as a Therapeutic Strategy for Acute Ischemic Stroke. The AAPS Journal, 19, 957-972. https://doi.org/10.1208/s12248-017-0091-7
|
[42]
|
Wang, L., Deng, L., Yuan, R., et al. (2020) Association of Matrix Metalloproteinase 9 and Cellular Fibronectin and Outcome in Acute Ischemic Stroke: A Systematic Review and Meta-Analysis. Frontiers in Neurology, 11, Article ID: 523506. https://doi.org/10.3389/fneur.2020.523506
|
[43]
|
Beker, M.C., Caglayan, A.B., Altunay, S., et al. (2022) Phosphodiesterase 10A Is a Critical Target for Neuroprotection in a Mouse Model of Ischemic Stroke. Molecular Neurobiology, 59, 574-589. https://doi.org/10.1007/s12035-021-02621-5
|
[44]
|
Bernardo-Castro, S., Sousa, J.A., Brás, A., et al. (2020) Pathophysiology of Blood-Brain Barrier Permeability throughout the Different Stages of Ischemic Stroke and Its Implication on Hemorrhagic Transformation and Recovery. Frontiers in Neurology, 11, Article ID: 594672. https://doi.org/10.3389/fneur.2020.594672
|
[45]
|
Datta, A., Sarmah, D., Kaur, H., et al. (2022) Post-Stroke Impairment of the Blood-Brain Barrier and Perifocal Vasogenic Edema Is Alleviated by Endovascular Mesenchymal Stem Cell Administration: Modulation of the PKCδ/MMP9/ AQP4-Mediated Pathway. Molecular Neurobiology, 59, 2758-2775. https://doi.org/10.1007/s12035-022-02761-2
|
[46]
|
Li, S., Li, Y., Huang, S., et al. (2020) Silencing Matrix Metalloproteinase 9 Exerts a Protective Effect on Astrocytes after Oxygen-Glucose Deprivation and Is Correlated with Suppression of Aquaporin-4. Neuroscience Letters, 731, Article ID: 135047. https://doi.org/10.1016/j.neulet.2020.135047
|
[47]
|
Bellut, M., Papp, L., Bieber, M., et al. (2021) NLPR3 Inflammasome Inhibition Alleviates Hypoxic Endothelial Cell Death in Vitro and Protects Blood-Brain Barrier Integrity in Murine Stroke. Cell Death & Disease, 13, Article No. 20. https://doi.org/10.1038/s41419-021-04379-z
|
[48]
|
Xiong, M., Feng, Y., Huang, S., et al. (2022) Teriparatide Induces Angiogenesis in Ischemic Cerebral Infarction Zones of Rats through AC/PKA Signaling and Reduces Ischemia-Reperfusion Injury. Biomedicine & Pharmacotherapy, 148, Article ID: 112728. https://doi.org/10.1016/j.biopha.2022.112728
|
[49]
|
Mechtouff, L., Bochaton, T., Paccalet, A., et al. (2020) Matrix Metalloproteinase-9 Relationship with Infarct Growth and Hemorrhagic Transformation in the Era of Thrombectomy. Frontiers in Neurology, 11, Article No. 473. https://doi.org/10.3389/fneur.2020.00473
|
[50]
|
Li, G., Morris-Blanco, K.C., Lopez, M.S., et al. (2018) Impact of MicroRNAs on Ischemic Stroke: from Pre-to Post-Disease. Progress in Neurobiology, 163-164, 59-78. https://doi.org/10.1016/j.pneurobio.2017.08.002
|
[51]
|
Wu, N., Gu, T., Lu, L., et al. (2019) Roles of MiRNA-1 and MiRNA-133 in the Proliferation and Differentiation of Myoblasts in Duck Skeletal Muscle. Journal of Cellular Physiology, 234, 3490-3499. https://doi.org/10.1002/jcp.26857
|
[52]
|
Selvamani, A., Sathyan, P., Miranda, R.C., et al. (2012) An Antagomir to MicroRNA Let7f Promotes Neuroprotection in an Ischemic Stroke Model. PLOS ONE, 7, E32662. https://doi.org/10.1371/journal.pone.0032662
|
[53]
|
Talebi, A., Rahnema, M. and Bigdeli, M.R. (2019) Effect of Intravenous Injection of AntagomiR-1 on Brain Ischemia. Molecular Biology Reports, 46, 1149-1155. https://doi.org/10.1007/s11033-018-04580-y
|
[54]
|
Yu, X. and Li, X. (2020) MicroRNA-1906 Protects Cerebral Ischemic Injury through Activating Janus Kinase 2/Signal Transducer and Activator of Transcription 3 Pathway in Rats. Neuroreport, 31, 871-878. https://doi.org/10.1097/WNR.0000000000001456
|
[55]
|
Yu, W., Rives, J., Welch, B., et al. (2009) Hypoplasia or Occlusion of the Ipsilateral Cranial Venous Drainage Is Associated with Early Fatal Edema of Middle Cerebral Artery Infarction. Stroke, 40, 3736-3739. https://doi.org/10.1161/STROKEAHA.109.563080
|
[56]
|
Faizy, T.D., Kabiri, R., Christensen, S., et al. (2021) Venous Outflow Profiles Are Linked to Cerebral Edema Formation at Noncontrast Head CT after Treatment in Acute Ischemic Stroke Regardless of Collateral Vessel Status at CT Angiography. Radiology, 299, 682-690. https://doi.org/10.1148/radiol.2021203651
|
[57]
|
Faizy, T.D., Kabiri, R., Christensen, S., et al. (2021) Association of Venous Outflow Profiles and Successful Vessel Reperfusion after Thrombectomy. Neurology, 96, E2903-E2911. https://doi.org/10.1212/WNL.0000000000012106
|
[58]
|
He, H.Y., Ren, L., Guo, T., et al. (2019) Neuronal Autophagy Aggravates Microglial Inflammatory Injury by Downregulating CX3CL1/Fractalkine after Ischemic Stroke. Neural Regeneration Research, 14, 280-288. https://doi.org/10.4103/1673-5374.244793
|
[59]
|
Mulder, I.A., Van Bavel, E.T., De Vries, H.E., et al. (2021) Adjunctive Cytoprotective Therapies in Acute Ischemic Stroke: A Systematic Review. Fluids and Barriers of the CNS, 18, Article No. 46. https://doi.org/10.1186/s12987-021-00280-1
|
[60]
|
Qiu, Y.M., Zhang, C.L., Chen, A.Q., et al. (2021) Immune Cells in the BBB Disruption after Acute Ischemic Stroke: Targets for Immune Therapy? Frontiers in Immunology, 12, Article ID: 678744. https://doi.org/10.3389/fimmu.2021.678744
|
[61]
|
Dhanesha, N., Jain, M., Tripathi, A.K., et al. (2020) Targeting Myeloid-Specific Integrin α9β1 Improves Short-and Long-Term Stroke Outcomes in Murine Models with Preexisting Comorbidities by Limiting Thrombosis and Inflammation. Circulation Research, 126, 1779-1794. https://doi.org/10.1161/CIRCRESAHA.120.316659
|
[62]
|
Hou, Y., Yang, D., Xiang, R., et al. (2019) N2 Neutrophils May Participate in Spontaneous Recovery after Transient Cerebral Ischemia by Inhibiting Ischemic Neuron Injury in Rats. International Immunopharmacology, 77, Article ID: 105970. https://doi.org/10.1016/j.intimp.2019.105970
|
[63]
|
Bonaventura, A., Liberale, L., Vecchié, A., et al. (2016) Update on Inflammatory Biomarkers and Treatments in Ischemic Stroke. International Journal of Molecular Sciences, 17, Article No. 1967. https://doi.org/10.3390/ijms17121967
|
[64]
|
Kanazawa, M., Takahashi, T., Nishizawa, M., et al. (2017) Therapeutic Strategies to Attenuate Hemorrhagic Transformation after Tissue Plasminogen Activator Treatment for Acute Ischemic Stroke. Journal of Atherosclerosis and Thrombosis, 24, 240-253. https://doi.org/10.5551/jat.RV16006
|
[65]
|
Lin, S.Y., Wang, Y.Y., Chang, C.Y., et al. (2021) TNF-α Receptor Inhibitor Alleviates Metabolic and Inflammatory Changes in a Rat Model of Ischemic Stroke. Antioxidants (Basel), 10, Article No. 851. https://doi.org/10.3390/antiox10060851
|
[66]
|
Howell, J.A. and Bidwell, G.R. (2020) Targeting the NF-κB Pathway for Therapy of Ischemic Stroke. Therapeutic Delivery, 11, 113-123. https://doi.org/10.4155/tde-2019-0075
|
[67]
|
Zhou, Y.F., Li, Y.N., Jin, H.J., et al. (2018) Sema4D/PlexinB1 Inhibition Ameliorates Blood-Brain Barrier Damage and Improves Outcome after Stroke in Rats. FASEB Journal, 32, 2181-2196. https://doi.org/10.1096/fj.201700786RR
|
[68]
|
Stokum, J.A., Gerzanich, V., Sheth, K.N., et al. (2020) Emerging Pharmacological Treatments for Cerebral Edema: Evidence from Clinical Studies. The Annual Review of Pharmacology and Toxicology, 60, 291-309. https://doi.org/10.1146/annurev-pharmtox-010919-023429
|
[69]
|
Shah, A., Almenawer, S. and Hawryluk, G. (2019) Timing of Decompressive Craniectomy for Ischemic Stroke and Traumatic Brain Injury: A Review. Frontiers in Neurology, 10, Article No. 11. https://doi.org/10.3389/fneur.2019.00011
|
[70]
|
Kimberly, W.T., Bevers, M.B., Von Kummer, R., et al. (2018) Effect of IV Glyburide on Adjudicated Edema Endpoints in the GAMES-RP Trial. Neurology, 91, E2163-E2169. https://doi.org/10.1212/WNL.0000000000006618
|
[71]
|
Zhang, J., Bhuiyan, M., Zhang, T., et al. (2020) Modulation of Brain Cation-Cl(−) Cotransport via the SPAK Kinase Inhibitor ZT-1a. Nature Communications, 11, Article No. 78. https://doi.org/10.1038/s41467-019-13851-6
|
[72]
|
Wang, Q., Deng, Y., Huang, L., et al. (2019) Hypertonic Saline Downregulates Endothelial Cell-Derived VEGF Expression and Reduces Blood-Brain Barrier Permeability Induced by Cerebral Ischaemia via the VEGFR2/ENOS Pathway. International Journal of Molecular Medicine, 44, 1078-1090. https://doi.org/10.3892/ijmm.2019.4262
|
[73]
|
Zuo, X., Lu, J., Manaenko, A., et al. (2019) MicroRNA-132 Attenuates Cerebral Injury by Protecting Blood-Brain-Barrier in MCAO Mice. Experimental Neurology, 316, 12-19. https://doi.org/10.1016/j.expneurol.2019.03.017
|
[74]
|
Sadeghian, N., Shadman, J., Moradi, A., et al. (2019) Calcitriol Protects the Blood-Brain Barrier Integrity against Ischemic Stroke and Reduces Vasogenic Brain Edema via Antioxidant and Antiapoptotic Actions in Rats. Brain Research Bulletin, 150, 281-289. https://doi.org/10.1016/j.brainresbull.2019.06.010
|
[75]
|
Sheth, K.N., Kimberly, W.T., Elm, J.J., et al. (2014) Exploratory Analysis of Glyburide as a Novel Therapy for Preventing Brain Swelling. Neurocritical Care, 21, 43-51. https://doi.org/10.1007/s12028-014-9970-2
|
[76]
|
Sheth, K.N., Petersen, N.H., Cheung, K., et al. (2018) Long-Term Outcomes in Patients Aged ≤ 70 Years with Intravenous Glyburide from the Phase II GAMES-RP Study of Large Hemispheric Infarction: An Exploratory Analysis. Stroke, 49, 1457-1463. https://doi.org/10.1161/STROKEAHA.117.020365
|